Compare BSAC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSAC | BIO |
|---|---|---|
| Founded | 1977 | 1952 |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 8.0B |
| IPO Year | 2002 | 1994 |
| Metric | BSAC | BIO |
|---|---|---|
| Price | $35.12 | $387.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $33.00 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 257.5K | 251.5K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | N/A | ★ 142.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,583,200,000.00 |
| Revenue This Year | $37.15 | $2.74 |
| Revenue Next Year | $7.52 | $3.20 |
| P/E Ratio | $14.40 | ★ N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $23.71 | $236.73 |
| 52 Week High | $37.72 | $396.23 |
| Indicator | BSAC | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 53.96 | 75.57 |
| Support Level | $34.89 | $289.16 |
| Resistance Level | $36.00 | N/A |
| Average True Range (ATR) | 0.77 | 11.00 |
| MACD | -0.03 | 1.25 |
| Stochastic Oscillator | 51.94 | 79.98 |
Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.